STAT+: A political contest in the U.K. could shake up drug pricing

The political landscape in the U.K. is poised for potential changes that could impact drug pricing, as U.S. officials recently urged Germany to increase its pharmaceutical expenditures. This development highlights the ongoing international discussions surrounding drug costs and access to medicines, which are critical issues in the biotech sector. The outcome of these political contests could have significant implications for the industry.